PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jpnSubmit a ManuscriptEmail AlertsAbout JPNJournal of Psychiatry and Neuroscience
 
J Psychiatry Neurosci. 1993 March; 18(2): 61–66.
PMCID: PMC1188487

The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.

Abstract

Studies suggest that 80% to 90% of all patients in the manic state respond to lithium provided that they are relatively free of dysphoria ("pure mania"). In contrast, less than 40% of individuals in the manic state who cycle rapidly or are substantially dysphoric ("dysphoric mania") respond to lithium. These patients appear to be more responsive to carbamazepine and valproate. The authors conclude that carbamazepine and valproate are the drugs of choice if one desires to treat a rapidly cycling individual or patient with dysphoric mania with just one agent. However, they emphasize that a prospective study designed to identify the predictors of response of primary mania to lithium, carbamazepine and valproate is required. Studies assessing the relative value of lithium, carbamazepine or valproate as prophylactic agents in the care of patients with specific subtypes of mania are also needed. These studies would address the most important issues confronting researchers interested in the drug treatment of mania.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Angst J, Weis P, Grof P, Baastrup PC, Schou M. Lithium prophylaxis in recurrent affective disorders. Br J Psychiatry. 1970 Jun;116(535):604–614. [PubMed]
  • Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Commun Psychopharmacol. 1978;2(2):159–175. [PubMed]
  • Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry. 1980 Jul;137(7):782–790. [PubMed]
  • Beigel A, Murphy DL. Unipolar and bipolar affective illness. Differences in clinical characteristics accompanying depression. Arch Gen Psychiatry. 1971 Mar;24(3):215–220. [PubMed]
  • Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry. 1990 Apr;147(4):431–434. [PubMed]
  • Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry. 1974 Feb;30(2):229–233. [PubMed]
  • Dunner DL, Patrick V, Fieve RR. Rapid cycling manic depressive patients. Compr Psychiatry. 1977 Nov-Dec;18(6):561–566. [PubMed]
  • Emrich HM, von Zerssen D, Kissling W, Möller HJ, Windorfer A. Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Arch Psychiatr Nervenkr. 1980;229(1):1–16. [PubMed]
  • Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry. 1992 Jan;149(1):108–111. [PubMed]
  • Himmelhoch JM, Garfinkel ME. Sources of lithium resistance in mixed mania. Psychopharmacol Bull. 1986;22(3):613–620. [PubMed]
  • Himmelhoch JM, Mulla D, Neil JF, Detre TP, Kupfer DJ. Incidence and signficiance of mixed affective states in a bipolar population. Arch Gen Psychiatry. 1976 Sep;33(9):1062–1066. [PubMed]
  • Jamison KR, Gerner RH, Goodwin FK. Patient and physician attitudes toward lithium: relationship to compliance. Arch Gen Psychiatry. 1979 Jul 20;36(8 Spec No):866–869. [PubMed]
  • Joyce PR. Carbamazepine in rapid cycling bipolar affective disorder. Int Clin Psychopharmacol. 1988 Apr;3(2):123–129. [PubMed]
  • Keller MB, Lavori PW, Coryell W, Andreasen NC, Endicott J, Clayton PJ, Klerman GL, Hirschfeld RM. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA. 1986 Jun 13;255(22):3138–3142. [PubMed]
  • Kukopulos A, Caliari B, Tundo A, Minnai G, Floris G, Reginaldi D, Tondo L. Rapid cyclers, temperament, and antidepressants. Compr Psychiatry. 1983 May-Jun;24(3):249–258. [PubMed]
  • Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S. Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry. 1987 Mar;48(3):89–93. [PubMed]
  • Lusznat RM, Murphy DP, Nunn CM. Carbamazepine vs lithium in the treatment and prophylaxis of mania. Br J Psychiatry. 1988 Aug;153:198–204. [PubMed]
  • Maarbjerg K, Aagaard J, Vestergaard P. Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence. Pharmacopsychiatry. 1988 May;21(3):121–125. [PubMed]
  • Maj M, Pirozzi R, Kemali D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology (Berl) 1989;98(4):535–538. [PubMed]
  • McElroy SL, Keck PE, Jr, Pope HG., Jr Sodium valproate: its use in primary psychiatric disorders. J Clin Psychopharmacol. 1987 Feb;7(1):16–24. [PubMed]
  • McElroy SL, Keck PE, Jr, Pope HG, Jr, Hudson JI. Valproate in the treatment of rapid-cycling bipolar disorder. J Clin Psychopharmacol. 1988 Aug;8(4):275–279. [PubMed]
  • McElroy SL, Keck PE, Jr, Pope HG, Jr, Hudson JI. Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. J Clin Psychopharmacol. 1992 Feb;12(1 Suppl):42S–52S. [PubMed]
  • Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi R, Hazama H, Mori A, Watanabe M. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study. Psychopharmacology (Berl) 1979;66(3):211–217. [PubMed]
  • Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi R, Hazama H, Mori A, Watanabe S. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology (Berl) 1981;73(1):95–96. [PubMed]
  • Polatin P, Fieve RR. Patient rejection of lithium carbonate prophylaxis. JAMA. 1971 Nov 8;218(6):864–866. [PubMed]
  • Pope HG, Jr, McElroy SL, Keck PE, Jr, Hudson JI. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry. 1991 Jan;48(1):62–68. [PubMed]
  • Post RM, Rubinow DR, Uhde TW, Roy-Byrne PP, Linnoila M, Rosoff A, Cowdry R. Dysphoric mania. Clinical and biological correlates. Arch Gen Psychiatry. 1989 Apr;46(4):353–358. [PubMed]
  • Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Correlates of antimanic response to carbamazepine. Psychiatry Res. 1987 May;21(1):71–83. [PubMed]
  • Post RM, Berrettini W, Uhde TW, Kellner C. Selective response to the anticonvulsant carbamazepine in manic-depressive illness: a case study. J Clin Psychopharmacol. 1984 Aug;4(4):178–185. [PubMed]
  • Prien RF. Methods and models for placebo use in pharmacotherapeutic trials. Psychopharmacol Bull. 1988;24(1):4–8. [PubMed]
  • Prien RF, Caffey EM, Jr, Klett CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry. 1972 Feb;26(2):146–153. [PubMed]
  • Prien RF, Gelenberg AJ. Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiatry. 1989 Jul;146(7):840–848. [PubMed]
  • Prien RF, Himmelhoch JM, Kupfer DJ. Treatment of mixed mania. J Affect Disord. 1988 Jul-Aug;15(1):9–15. [PubMed]
  • Secunda SK, Katz MM, Swann A, Koslow SH, Maas JW, Chuang S, Croughan J. Mania. Diagnosis, state measurement and prediction of treatment response. J Affect Disord. 1985 Mar-Apr;8(2):113–121. [PubMed]
  • SCHOU M, JUEL-NIELSEN N, STROMGREN E, VOLDBY H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954 Nov;17(4):250–260. [PMC free article] [PubMed]
  • Secunda S, Koslow SH, Redmond DE, Garver D, Ramsey TA, Croughan J, Kocsis J, Hanin I, Lieberman K, Casper R. Biological component of the NIMH clinical research branch collaborative program on the psychobiology of depression: II. Methodology and data analysis. Psychol Med. 1980 Nov;10(4):777–793. [PubMed]
  • Sedler MJ. Falret's discovery: the origin of the concept of bipolar affective illness. Translated by M. J. Sedler and Eric C. Dessain. Am J Psychiatry. 1983 Sep;140(9):1127–1133. [PubMed]
  • Swann AC, Secunda SK, Katz MM, Koslow SH, Maas JW, Chang S, Robins E. Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome. Psychiatry Res. 1986 Jun;18(2):127–141. [PubMed]
  • Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry. 1988 Feb;145(2):179–184. [PubMed]
  • Weissman MM, Leaf PJ, Tischler GL, Blazer DG, Karno M, Bruce ML, Florio LP. Affective disorders in five United States communities. Psychol Med. 1988 Feb;18(1):141–153. [PubMed]

Articles from Journal of Psychiatry & Neuroscience : JPN are provided here courtesy of Canadian Medical Association